Monoclonal antibodies
Sub categories/Drugs:
- L01XC01: edrecolomab
- L01XC02: rituximab
- L01XC03: trastuzumab
- L01XC05: gemtuzumab ozogamicin
- L01XC06: cetuximab
- L01XC07: bevacizumab (Avastin®)
- L01XC08: panitumumab
- L01XC09: catumaxomab
- L01XC10: ofatumumab
- L01XC11: ipilimumab
- L01XC12: brentuximab vedotin
- L01XC13: pertuzumab
- L01XC14: trastuzumab emtansine
- L01XC15: obinutuzumab
- L01XC16: dinutuximab beta
- L01XC17: nivolumab
Description:
Clinical Syndromes:
Morphological Classes:
References:
NOTE: the following reference list is generated automatically and has not yet been verified.
Automatic PUBMED search: ("Monoclonal antibodies/adverse effects"[Mesh] OR "Monoclonal antibodies/toxicity"[Mesh]) AND (nephrotoxicity OR "Kidney Diseases/chemically induced"[Mesh] OR "Kidney Diseases/pathology"[Mesh] OR "Kidney Diseases/physiopathology"[Mesh])
loading references for 'Monoclonal antibodies' from pubmed ...
Case Reports: